Loading…
Hims & Hers Health, Inc. is projected to rise to $29.27 by 2027, a +8% move from its current price of $27.04. HIMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $25.52 | $27.02 | $28.61 | -0.07% |
| Aug 2 | $24.90 | $27.00 | $29.28 | -0.13% |
| Aug 3 | $24.44 | $26.99 | $29.80 | -0.20% |
| Aug 4 | $24.05 | $26.97 | $30.24 | -0.26% |
| Aug 5 | $23.71 | $26.95 | $30.63 | -0.33% |
| Aug 6 | $23.41 | $26.93 | $30.99 | -0.39% |
| Aug 7 | $23.13 | $26.92 | $31.32 | -0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.13 | $26.92 | $31.32 | -0.46% |
| Week 2 | $21.63 | $26.79 | $33.20 | -0.91% |
| Week 3 | $20.52 | $26.67 | $34.68 | -1.36% |
| Week 4 | $19.61 | $26.55 | $35.95 | -1.81% |
| Week 5 | $18.84 | $26.43 | $37.09 | -2.26% |
| Week 6 | $18.15 | $26.31 | $38.13 | -2.70% |
| Week 7 | $17.54 | $26.19 | $39.10 | -3.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.
The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Hims & Hers Health, Inc. trades at $27.04 with a market capitalization of $6.26B and a rank of 1125. The current price sits near a defined technical frontier, with a 30-day range of $18.54 to $39.44 and notable intraday volatility.
The forecast provides a multi-year path of upside potential, with the average price climbing across years and substantial increases in later periods. The 2026 average price is $27.04, rising to $60.09 by 2030, and reaching $393.23 on average by 2050, with corresponding ROI expanding from 0% in 2026 to 1354.3% in 2050.
A major floor 37.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.5% below — buyers have tended to step in here.
The nearest ceiling, 41.6% above — a clean break opens room to run.
A major ceiling 60.5% above — clearing it would confirm fresh momentum.
Key HIMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HIMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.94 | Sell | $28.07 | Sell |
| MA 10 | $30.24 | Sell | $29.77 | Sell |
| MA 20 | $33.00 | Sell | $31.24 | Sell |
| MA 50 | $30.62 | Sell | $30.67 | Sell |
| MA 100 | $27.46 | Sell | $29.66 | Sell |
| MA 200 | $30.47 | Sell | $31.16 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.60 | Neutral |
| Stoch RSI (14) | 20.12 | Neutral |
| CCI (20) | -143.98 | Sell |
| Williams %R (14) | -83.24 | Info |
| MACD (12,26,9) | -1.10 | Sell |
| ROC (12) | -23.07 | Sell |
| Bollinger %B (20,2) | 0.07 | Neutral |
| Stochastic %K (14) | 16.76 | Buy |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | -4.89 | Sell |
| Ultimate (7,14,28) | 33.92 | Neutral |
| Momentum (10) | -6.64 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 26.19 | Buy |
| ADX (14) | 17.54 | Neutral |
| ATR (14) | 1.62 | Info |
The 30-day technical picture is neutral. The RSI(14) is 40, indicating room to move before overbought conditions. The stock trades near a 50-day simple moving average of $30.62 and a 200-day simple moving average of $30.47, reflecting mid-term price processing around the $30 area.
Support is noted at $25.00 and resistance at $38.28, suggesting a defined corridor in the near term. The 30-day range spans from $18.54 to $39.44, highlighting recent volatility within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.52 | $27.04 | $32.92 | 0% | Neutral | |
| $21.31 | $29.27 | $43.45 | +8% | Neutral | |
| $26.75 | $39.06 | $61.86 | +44% | Bullish | |
| $34.83 | $53.60 | $89.15 | +98% | Bullish | |
| $37.24 | $60.09 | $104.08 | +122% | Bullish | |
| $41.45 | $69.92 | $125.40 | +159% | Bullish | |
| $40.71 | $71.63 | $132.48 | +165% | Bullish | |
| $36.60 | $67.06 | $127.50 | +148% | Bullish | |
| $41.58 | $79.26 | $154.53 | +193% | Bullish | |
| $48.64 | $96.39 | $192.30 | +256% | Bullish | |
| $70.08 | $155.74 | $341.58 | +476% | Bullish | |
| $176.95 | $393.23 | $904.44 | +13.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $14.52 | $27.04 | $31.70 | +0.00% |
| August 2026 | $21.61 | $25.88 | $32.09 | -4.29% |
| September 2026 | $20.92 | $25.48 | $32.41 | -1.54% |
| October 2026 | $21.61 | $26.68 | $34.60 | +4.70% |
| November 2026 | $20.94 | $26.15 | $34.45 | -1.99% |
| December 2026 | $19.53 | $24.63 | $32.92 | -5.79% |
Click any year to see its month-by-month HIMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect HIMS to range from $14.52 to $32.92 through 2026. The $27.04 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The HIMS price prediction for 2027 points to an average of $29.27 (low $21.31, high $43.45) — a potential gain of +8% on today's $27.04. A consolidation phase looks the most probable path here.
In 2028, HIMS is projected to trade between $26.75 and $61.86, averaging $39.06 — a potential gain of +44% from today's $27.04. That is up +33% on the projected 2027 average. Momentum favours further upside here.
Hims & Hers Health, Inc.'s 2029 outlook centres on $53.60, within a $34.83 to $89.15 range. That is up +37% on the projected 2028 average. That marks a +98% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, HIMS could reach as high as $104.08, with a base case around $60.09 and support toward $37.24 — roughly +122% from $27.04. Momentum favours further upside here.
Expect HIMS to range from $41.45 to $125.40 through 2031. The $69.92 average target implies a +159% move from current prices. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The HIMS price prediction for 2032 points to an average of $71.63 (low $40.71, high $132.48) — a potential gain of +165% on today's $27.04. Momentum favours further upside here.
In 2033, HIMS is projected to trade between $36.60 and $127.50, averaging $67.06 — a potential gain of +148% from today's $27.04. That is -6% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Hims & Hers Health, Inc.'s 2034 outlook centres on $79.26, within a $41.58 to $154.53 range. That is up +18% on the projected 2033 average. That marks a +193% change versus current levels. Momentum favours further upside here.
By 2035, HIMS could reach as high as $192.30, with a base case around $96.39 and support toward $48.64 — roughly +256% from $27.04. Buyers look set to stay in control over this stretch.
Expect HIMS to range from $70.08 to $341.58 through 2040. The $155.74 average target implies a +476% move from current prices. That is up +62% on the projected 2035 average. Momentum favours further upside here.
The HIMS price prediction for 2050 points to an average of $393.23 (low $176.95, high $904.44) — a potential gain of +13.5x on today's $27.04. Buyers look set to stay in control over this stretch.
Investing $1,000 in HIMS today (≈ 36.982249 HIMS) could be worth
$14,542.64
+$13,542.64 (+1354%) by 2050 · US Dollar
Based on the average projected HIMS price of $393.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HIMSwould be worth at today's price.
$1,000 invested in HIMS on Jul 30, 2025 (≈ 15.260186 HIMS) would be worth
$412.64
-$587.36 (-58.7%) today · 0.41× · US Dollar
Based on a HIMS entry price of $65.53 vs. today's $27.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $32.74 | $825.9 | -17.4% |
| 1 month ago | $34.67 | $779.93 | -22.0% |
| 3 months ago | $27.41 | $986.5 | -1.3% |
| 6 months ago | $27.09 | $998.15 | -0.2% |
| 1 year ago | $65.53 | $412.64 | -58.7% |
| All time (5.0y) ago | $8.07 | $3,350.68 | +235.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HIMS forecast.
Our base-case forecast reaches $54.00 around 2030.
Implied market cap at $54.00: $12.05B
The multi-year forecast points to a bullish trajectory with meaningful upside through the end of the decade and beyond. The year-by-year averages show a path from $27.04 in 2026 to $29.27 in 2027, $39.06 in 2028, and $53.60 in 2029, with 2030 averaging $60.09 and a 122.2% ROI. The gains continue through 2031 at $69.92 (158.6% ROI) and 2032 at $71.63 (164.9% ROI), then pull back slightly in 2033 to $67.06 before rising again to $79.26 in 2034 and $96.39 in 2035, with higher ROIs along the way.
By 2040, the average price is forecast at $155.74 with a 476% ROI and a max forecast of $341.58. By 2050, the average is expected to be $393.23 with a max of $904.44 and a very large 1354.3% ROI. These figures illustrate a long-run bullish scenario, but they are estimates, not guarantees, and are subject to variability and risk from market dynamics and company-specific developments.
Tap a question to reveal the answer.
Avg $60.09; Max $104.08; Min $37.24; ROI 122.2%.
The forecast shows a bullish path beyond 2027, with the 2030 avg $60.09 and the 2050 avg $393.23, accompanied by an ROI up to 1354.3%, though these are estimates and not guarantees.
Yes—the forecast max rises to $341.58 by 2040 and to $904.44 by 2050.
Avg $155.74; Max $341.58; ROI 476%.
Avg $393.23; Max $904.44; ROI 1354.3%.
Hims & Hers Health, Inc. Community Discussion
0Share your Hims & Hers Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.